Asia-Pacific - Australia - Austria - Canada - Ethiopia - Europe - Europe, United States - France - Germany - Greece - Gulf Cooperation Council - International - Israel - Italy - Kyrgyzstan - Libya - Mauritania - New Zealand - Nigeria - North Africa - Qatar - Romania - Slovakia - South America - Spain - Switzerland - Taiwan - Türkiye - United Kingdom - United States - WHO - {Related topics}

Asia-Pacific

• World Journal of Gastroenterology
  • Hepatitis D: Scenario in the Asia-Pacific region [2010]

Australia

• Australian Journal of General Practice
  • Management of hepatitis D in general practice [2023]

• Medical Journal of Australia
  • Reflex Testing for Hepatitis D Infection: A Unique Opportunity to Reduce Hepatitis D-Related Chronic Liver Disease Deaths in Australia [2026]

• Queensland Health
  • Hepatitis D

• SA Health
  • Hepatitis D - including symptoms, treatment and prevention

Austria

• JHEP Reports
  • Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study [2026]

• United European Gastroenterology Journal
  • Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis [2021]

Canada

• JHEP Reports
  • Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada [2022]

• Public Health Agency of Canada
  • Hepatitis D Virus
  • Hepatitis D

Ethiopia

• International Journal of Infectious Diseases
  • A new hepatitis delta virus hotspot in Ethiopia: A multicenter study [2026]

Europe

• European Association for the Study of the Liver
  • EASL Clinical Practice Guidelines on hepatitis delta virus [2023]

• Journal of Viral Hepatitis
  • Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update [2025]

• Liver International
  • From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management [2026]

Europe, United States

• American Association for the Study of Liver Diseases
  • Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV/HDV treatment endpoints conference [2023]

France

• BMC Public Health
  • Screening tests for hepatitis B, C and D in metropolitan France from 2016 to 2022: a map based on the National Health Data System with a focus on HDV hepatitis [2025]

• Liver International
  • Bulevirtide in Chronic Hepatitis D Patients Awaiting Liver Transplantation Results From a French Multicentric Retrospective Study [2025]
  • The diagnostic cascade for patients with hepatitis delta infection in France, 2018-2022: A cross-sectional study [2024]

• Viruses
  • Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France [2026]

Germany

• Alimentary Pharmacology & Therapeutics
  • Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting [2025]

Greece

• Journal of Viral Hepatitis
  • HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D [2026]

• Liver International
  • HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D [2025]

Gulf Cooperation Council

• Saudi Journal of Gastroenterology
  • Multisociety consensus recommendations on hepatitis delta virus infection [2025]

International

• Amino Acids
  • Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D [2025]

• Antiviral Therapy
  • Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines [2025]

• Current Gastroenterology Reports
  • Hepatitis Delta: Epidemiology, Diagnosis and Management 36 Years After Discovery [2014]

• Current Hepatology Reports
  • Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies [2024]

• Frontiers in Cellular and Infection Microbiology
  • Current and future therapeutic options for chronic hepatitis D virus infection [2025]

• Gut Pathogens
  • Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis [2021]

• Hepatology
  • HDV RNA assays: Performance characteristics, clinical utility, and challenges [2025]

• Journal of Hepatology
  • The global prevalence of hepatitis D virus infection: systematic review and meta-analysis [2020]

• Journal of Viral Hepatitis
  • The elimination of hepatitis D as a public health problem: Needs and challenges [2024]

• Pathogens
  • Hepatitis Delta Virus Infection: An Overview [2025]

• Viruses
  • Updates on Recent Advancements in Hepatitis D Virus Treatment [2025]
  • A Review of HDV Infection [2022]

• World Journal of Gastroenterology
  • Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic [2021]
  • Chronic hepatitis delta: A state-of-the-art review and new therapies [2019]

• World Journal of Hepatology
  • Hepatitis delta virus: Making the point from virus isolation up to 2014 [2015]

Israel

• Virology Journal
  • Epidemiology of hepatitis delta virus (HDV) infection and comparison of clinical characteristics and disease progression among patients with HDV vs. hepatitis B mono-infection: real-world data from a large healthcare insurer-provider in Israel [2025]

Italy

• American Journal of Transplantation
  • Liver transplantation for hepatitis D virus/hepatitis B virus coinfection in Italy: An intention-to-treat analysis of long-term outcomes [2025]

• Digestive and Liver Disease
  • AISF-SIMIT practice guidance on treatment of hepatitis d virus (HDV): A 2025 update [2026]

• Journal of Clinical Virology
  • Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study [2025]

• Journal of Viral Hepatitis
  • Changing Pattern of HDV Infection in Italy Over 40 Years; the Current Scenario and the Impending Challenge [2026]
  • Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study [2025]

• Liver International
  • The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm [2025]

• World Journal of Gastroenterology
  • Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort [2025]

Kyrgyzstan

• Viruses
  • Global Distribution and Natural Recombination of Hepatitis D Virus: Implication of Kyrgyzstan Emerging HDVs in the Clinical Outcomes [2022]

Libya

• Pan African Medical Journal
  • The epidemiological characterization and geographic distribution of hepatitis D virus infection in Libya [2020]

Mauritania

• Journal of Epidemiology and Global Health
  • Seroprevalence and Molecular Epidemiology of Hepatitis B and D Viruses in Mauritania: a Systematic Review and Meta-Analysis [2026]

New Zealand

• Health New Zealand
  • Hepatitis D Protocol

Nigeria

• Pathogens
  • Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study [2025]

• Viruses
  • The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study [2024]
  • Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024 [2024]

North Africa

• Scientific World Journal
  • The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis [2018]

Qatar

• Eastern Mediterranean Health Journal
  • Seroprevalence and clinical outcome of hepatitis D infection in Qatar [2022]

Romania

• Viruses
  • Unveiling Prevalence, Risk Factors, and Outcomes of Hepatitis D Among Vulnerable Communities in Romania [2024]

Slovakia

• Viruses
  • Is Slovakia Almost a Hepatitis D Free Country? [2023]

South America

• Revista da Sociedade Brasileira de Medicina Tropical
  • Hepatitis Delta Prevalence in South America: A Systematic Review and Meta-Analysis [2019]

Spain

• Alimentary Pharmacology & Therapeutics
  • Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain-DDR Study [2026]

• Gastroenterología y Hepatología
  • Cost analysis of hidden hepatitis D virus infection in Spain [2025]
  • Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D [2025]

Switzerland

• Swiss Medical Weekly
  • Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysis [2026]

Taiwan

• Pathogens
  • The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan [2021]

Türkiye

• Turkish Journal of Gastroenterology
  • Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines [2017]

United Kingdom

• National Institute for Health and Care Excellence
  • Bulevirtide for treating chronic hepatitis D [2023]

• UK Health Security Agency
  • Hepatitis D in England and the UK

United States

• American Gastroenterological Association
  • AGA Clinical Practice Update on Management of Hepatitis Delta: Commentary [2025]

• Centers for Disease Control and Prevention
  • Hepatitis D Virus Case Definition
  • Hepatitis D Basics

• Chronic Liver Disease Foundation
  • Diagnosis and Management of Hepatitis Delta Virus Infection [2023]

• Clinical Infectious Diseases
  • Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States [2025]

• Digestive Diseases and Sciences
  • Enhanced Screening for Hepatitis D in the USA: Overcoming the Delta Blues [2021]

• Journal of Applied Laboratory Medicine
  • Prevalence of Hepatitis D in the United States [2025]

• Journal of Viral Hepatitis
  • Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States [2026]
  • A US-Based Multi-Site Pilot to Screen Hepatitis B Surface Antigen-Positive Patients for Hepatitis D [2025]

• Open Forum Infectious Diseases
  • Hepatitis Delta Virus Reporting Requirements in the United States and Territories: A Systematic Review [2024]

WHO

• World Health Organization
  • Hepatitis D: Fact sheet

{Related topics}

• Topic
  • Hepatitis in pregnancy and newborn
  • Hepatitis B
  • Hepatitis
  • HIV/AIDS and hepatitis